Authors:
Lammering, G
Hewit, TH
Hawkins, WT
Contessa, JN
Reardon, DB
Lin, PS
Valerie, K
Dent, P
Mikkelsen, RB
Schmidt-Ullrich, RK
Citation: G. Lammering et al., Epidermal growth factor receptor as a genetic therapy target for carcinomacell radiosensitization, J NAT CANC, 93(12), 2001, pp. 921-929
Authors:
Lammering, G
Valerie, K
Lin, PS
Mikkelsen, RB
Contessa, JN
Feden, JP
Farnsworth, J
Dent, P
Schmidt-Ullrich, RK
Citation: G. Lammering et al., Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor, CLIN CANC R, 7(3), 2001, pp. 682-690
Authors:
Bowers, G
Reardon, D
Hewitt, T
Dent, P
Mikkelsen, RB
Valerie, K
Lammering, G
Amir, C
Schmidt-Ullrich, RK
Citation: G. Bowers et al., The relative role of ErbB1-4 receptor tyrosine kinases in radiation signaltransduction responses of human carcinoma cells (vol 20, pg 1388, 2001), ONCOGENE, 20(29), 2001, pp. 3927-3927
Authors:
Bowers, G
Reardon, D
Hewitt, T
Dent, P
Mikkelsen, RB
Valerie, K
Lammering, G
Amir, C
Schmidt-Ullrich, RK
Citation: G. Bowers et al., The relative role of ErbB1-4 receptor tyrosine kinases in radiation signaltransduction responses of human carcinoma cells, ONCOGENE, 20(11), 2001, pp. 1388-1397
Authors:
Manning, MA
Wu, QW
Cardinale, RM
Mohan, R
Lauve, AD
Kavanagh, BD
Morris, MM
Schmidt-Ullrich, RK
Citation: Ma. Manning et al., The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer, INT J RAD O, 51(5), 2001, pp. 1400-1409
Authors:
Lammering, G
Lin, PS
Contessa, JN
Hampton, JL
Valerie, K
Schmidt-Ullrich, RK
Citation: G. Lammering et al., Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells, INT J RAD O, 51(3), 2001, pp. 775-784
Authors:
Kavanagh, BD
Khandelwal, SR
Schmidt-Ullrich, RK
Roberts, JD
Shaw, EG
Pearlman, AD
Venitz, J
Dusenbery, KE
Abraham, DJ
Gerber, MJ
Citation: Bd. Kavanagh et al., A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: Tolerance of repeated intravenous doses and correlation of pharmacokinetics withpharmacodynamics, INT J RAD O, 49(4), 2001, pp. 1133-1139
Authors:
Kavanagh, BD
Segreti, EM
Koo, D
Amir, C
Arthur, D
Wheelock, J
Cardinale, RM
Schmidt-Ullrich, RK
Citation: Bd. Kavanagh et al., Long-term local control and survival after concomitant boost accelerated radiotherapy for locally advanced cervix cancer, AM J CL ONC, 24(2), 2001, pp. 113-119
Authors:
Manning, PA
Arthur, DW
Schmidt-Ullrich, RK
Arnfield, MR
Amir, C
Zwicker, RD
Citation: Pa. Manning et al., Interstitial high-dose-rate brachytherapy boost: The feasibility and cosmetic outcome of a fractionated outpatient delivery scheme, INT J RAD O, 48(5), 2000, pp. 1301-1306
Citation: Dg. Todd et al., Ionizing radiation stimulates existing signal transduction pathways involving the activation of epidermal growth factor receptor and ERBB-3, and changes of intracellular calcium in A431 human squamous carcinoma cells, J RECEPT SI, 19(6), 1999, pp. 885-908
Authors:
Contessa, JN
Reardon, DB
Todd, D
Dent, P
Mikkelsen, RB
Valerie, K
Bowers, GD
Schmidt-Ullrich, RK
Citation: Jn. Contessa et al., The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells, CLIN CANC R, 5(2), 1999, pp. 405-411
Authors:
Varghese, S
Schmidt-Ullrich, RK
Dritschilo, A
Jung, M
Citation: S. Varghese et al., Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient, RADIAT ON I, 7(4), 1999, pp. 231-237
Authors:
Wazer, DE
Jabro, G
Ruthazer, R
Schmid, C
Safaii, H
Schmidt-Ullrich, RK
Citation: De. Wazer et al., Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation, RADIAT ON I, 7(2), 1999, pp. 111-117
Authors:
Reardon, DB
Contessa, JN
Mikkelsen, RB
Valerie, K
Amir, C
Dent, P
Schmidt-Ullrich, RK
Citation: Db. Reardon et al., Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activationand enhance radiation toxicity of human mammary carcinoma cells, ONCOGENE, 18(33), 1999, pp. 4756-4766
Authors:
Wazer, DE
Schmidt-Ullrich, RK
Ruthazer, R
DiPetrillo, T
Boyle, T
Kanski, J
Safaii, H
Citation: De. Wazer et al., The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor, INT J RAD O, 45(4), 1999, pp. 885-891
Authors:
Arthur, DW
Schmidt-Ullrich, RK
Friedman, RB
Wazer, DE
Kachnic, LA
Amir, C
Bear, HD
Hackney, MH
Smith, TJ
Lawrence, W
Citation: Dw. Arthur et al., Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: Complete response predicts outcome and allows for breast conservation, INT J RAD O, 44(2), 1999, pp. 289-296
Authors:
Khandelwal, SR
Kavanagh, BD
Lin, PS
Troung, QT
Lu, J
Abraham, DJ
Schmidt-Ullrich, RK
Citation: Sr. Khandelwal et al., RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice, BR J CANC, 79(5-6), 1999, pp. 814-820
Authors:
Dent, P
Jarvis, WD
Birrer, MJ
Fisher, PB
Schmidt-Ullrich, RK
Grant, S
Citation: P. Dent et al., The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity, LEUKEMIA, 12(12), 1998, pp. 1843-1850